Kuros Biosciences AG (ETR:YTSN)
Germany
· Delayed Price · Currency is EUR 26.58
+0.06 (0.23%)
Last updated: Jun 25, 2025
Kuros Biosciences AG Revenue
In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M CHF with 125.11% growth.
Revenue
75.56M CHF
Revenue Growth
+179.89%
P/S Ratio
12.99
Revenue / Employee
619.30K CHF
Employees
122
Market Cap
1.05B EUR
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
| Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
| Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
| Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
| Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Healthineers AG | 23.14B |